An interventional study of Minimally invasive microsclerostomy in Glaucoma, sponsored by Hôpital Privé de la Baie. Completed at 3 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-01.
Sponsored by Hôpital Privé de la Baie · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Glaucoma with a site in France — 10 open to participants now, 11 under way, none of them phase 3. Glaucoma · France.
Among the 54 studies in Glaucoma with a site in France, this one is the 30th largest by enrollment of the 38 interventional ones that give a count, is one of 3 that started in 2024, is one of 29 with no phase, and was the 46th registered.
1,419 studies on the registry are indexed under Glaucoma; 220 are open to participants now.
Browse Glaucoma studies →10 of the 54 studies in Glaucoma with a site in France are open now. Recruiting first, the newest first:
Hôpital Privé de la Baie · Sites in France
Ages 18+
University Hospital, Bordeaux · Sites in France
Ages 18+
Hospices Civils de Lyon · Sites in France
Ages 18+
Hôpital Privé de la Baie · Sites in France
Ages 18+
Hôpital Privé de la Baie · Sites in France
Ages 18–80
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 154 Glaucoma studies recruiting now, 112 (73%) set no upper age limit and 9 (6%) stop at 75 or younger; 13 take children under 18; 44 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 23 is below the median of 61 across 964 interventional studies indexed under Glaucoma.
Median enrollment 105 across the 38 interventional studies, 120 across the 16 observational. Of the 36 that completed or were terminated, 8 (22%) have results posted.
This tab as a report to print or save as PDF → With an account.
20 of 54 have an industry lead sponsor. The 10 most frequent:
Hôpital Privé de la Baie is the lead sponsor of 4 studies on the registry; 3 are open to participants now.
Hôpital Privé de la Baie has 4 studies filed under Glaucoma — fewer than ten, so there is no comparison to draw.
4 of the studies in Glaucoma with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06274593Nantes University HospitalStudy of OCT Peripapillary Angiography in Patients With Advanced Glaucoma | 2027-04-27 |
| NCT07802769University Hospital, BordeauxMagnetic Resonance Imaging of Cerebral Connectivity and Volume in Neurodegeneration and Glaucoma | 2027-05 |
| NCT04129021Centre Hospitalier National d'Ophtalmologie des Quinze-VingtsHigh Resolution, High-speed Multimodal Ophthalmic Imaging | 2027-07 |
| NCT07303257Hospices Civils de LyonQuality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options | 2027-08 |
Add all 4 to your calendar (.ics) → With an account.
Among the 54 studies in Glaucoma with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The main objective is to evaluate the effectiveness of MIMS in patients with an indication for glaucoma surgery, compared to traditional surgery. The secondary objective is to assess safety. The investigating ophthalmologist will follow the patients and collect clinical data in order to identify the benefits and complications of MIMS. Patients are expected to experience fewer complications compared to traditional glaucoma surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Minimally invasive microsclerostomy
MIMS is a filtering glaucoma surgery, which consists of creating a sclero-corneal drainage channel, to allow the flow of aqueous humor and therefore the reduction of intraocular pressure. This surgery is extremely quick, lasting 3 to 5 minutes, according to recent MIMS studies, in contrast to the duration of a trabeculectomy, the classic glaucoma surgery, which varies between 20 and 60 minutes.
Measurement of intraocular pressure by tonometry
Measure in millimeters of mercury (mmHg)
Time frame: day 0, day 7, day 14, day 30, month 6, month 9 and month 12 after surgery
visual quality of life VFQ-25,
25 questions about visual quality of life with Likert scale (1-5 and 1-6)
Time frame: month 1, month 3, month 12 after surgery
Optical Coherence Tomography
high-resolution images of the retina and anterior segment
Time frame: month 3, month 12
Visual field test
Measure of visual field in degree (°)
Time frame: month 3, month 12
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2024 to primary completion in Mar 2026, 26 months.
Of 230 non-industry interventional studies with no phase under Glaucoma, half reached primary completion within 32 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 55. This study's 26 months is below that.
Counting every sponsor, half of 288 studies reached it within 30 months; a quarter within 12 and three quarters within 53.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hôpital Privé de la Baie